Medifast Q2 2024 Adj. EPS $0.92 Beats $0.39 Estimate, Sales $168.558M Miss $174.050M Estimate
Benzinga Newsdesk 2 years ago
EarningsEarnings BeatsEarnings MissesNews
Medifast (NYSE:MED) reported quarterly earnings of $0.92 per share which beat the analyst consensus estimate of $0.39 by 135.9 percent. The company reported quarterly sales of $168.558 million which missed the analyst
Medifast (NYSE:MED) reported quarterly earnings of $0.92 per share which beat the analyst consensus estimate of $0.39 by 135.9 percent. The company reported quarterly sales of $168.558 million which missed the analyst consensus estimate of $174.050 million by 3.16 percent. This is a 43.09 percent decrease over sales of $296.188 million the same period last year.